Lido Advisors LLC Buys 15,180 Shares of Astera Labs, Inc. $ALAB

Lido Advisors LLC boosted its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 123.4% during the first quarter, HoldingsChannel reports. The firm owned 27,477 shares of the company’s stock after buying an additional 15,180 shares during the period. Lido Advisors LLC’s holdings in Astera Labs were worth $3,012,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of ALAB. Royal Bank of Canada increased its holdings in shares of Astera Labs by 167.3% in the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after buying an additional 95,409 shares during the last quarter. AQR Capital Management LLC lifted its holdings in shares of Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after acquiring an additional 7,756 shares during the last quarter. Empowered Funds LLC grew its position in Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after acquiring an additional 4,183 shares in the last quarter. First Trust Advisors LP grew its position in Astera Labs by 102.0% in the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after acquiring an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. increased its stake in Astera Labs by 54.9% in the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after acquiring an additional 1,977 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ALAB. Stifel Nicolaus raised their price target on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. Jefferies Financial Group reiterated a “buy” rating and set a $270.00 price objective on shares of Astera Labs in a research report on Wednesday, May 6th. Needham & Company LLC raised their price objective on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Morgan Stanley upped their target price on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Finally, Evercore reiterated an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and a consensus price target of $282.00.

Astera Labs Stock Down 10.8%

NASDAQ ALAB opened at $291.58 on Friday. The company has a 50-day simple moving average of $358.95 and a two-hundred day simple moving average of $225.66. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The firm has a market cap of $49.98 billion, a price-to-earnings ratio of 197.01, a PEG ratio of 3.38 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company’s quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts expect that Astera Labs, Inc. will post 1.86 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Astera Labs news, CEO Jitendra Mohan sold 139,951 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $200.16, for a total value of $28,012,592.16. Following the completion of the sale, the chief executive officer owned 3,929,183 shares in the company, valued at approximately $786,465,269.28. The trade was a 3.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the sale, the director directly owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,676,845 shares of company stock worth $444,928,806 in the last ninety days. 10.40% of the stock is owned by insiders.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.